美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Palvella Therapeutics

24.43

-2.5400-9.42%

盤後：24.900.4700+1.92%17:06 EDT

成交量：7.98萬

成交額：198.18萬

市值：2.74億

市盈率：-3.12

高：26.39

開：25.00

低：24.00

收：26.97

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Palvella Therapeutics

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

125 Strafford Avenue,Suite 360,Wayne,Pennsylvania,United States

官網：

http://www.pieris.com

郵編：

19087

電話：

傳真：

- -

簡介：

Palvella Therapeutics, Inc.在內華達的法律下成立於2013年5月24日。該公司是一家生物技術公司，歷史上發現並開發了基於Anticalin蛋白的藥物，以獨特和變革性的方式靶向已驗證的疾病途徑。2024年3月27日，公司實施了措施，以最大限度地提高其從其合作候選藥物臨床管道收集潛在里程碑的能力，並保持其考慮其他戰略選擇的能力。該公司的臨床管線包括與合作者合作的免疫腫瘤學或IO雙特異性藥物，包括靶向PD-L1和4-1BB的S095012（也稱PRS-344）、靶向CD228和4-1BB的SGN-BB228（也稱PRS-346）以及靶向GPC3和4-1BB的BOS-342（也稱PRS-342）。Anticalin蛋白是公司專有的，是一類新型療法，已在臨床上通過與領先製藥公司的合作關係得到驗證。

董事

名稱

職位

James Geraghty

Director and Chairman

Stephen S. Yoder

Director,Chief Executive Officer and President

Ann Barbier

Director

Christopher Kiritsy

Director

Jean Pierre Bizzari

Director

Michael Richman

Director

Steven Prelack

Director

股東

名稱

職位

Stephen S. Yoder

Director,Chief Executive Officer and President

Allan Reine

Senior Vice President, Chief Financial Officer and Treasurer

Louis A. Matis

Senior Vice President and Chief Development Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PVLA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":24.43,"timestamp":1743710400000,"preClose":26.97,"halted":0,"volume":79818,"hourTrading":{"tag":"盘后","latestPrice":24.9,"preClose":24.43,"latestTime":"17:06 EDT","volume":3,"amount":73.759998,"timestamp":1743714382387},"delay":0,"floatShares":6497315,"shares":11221307,"eps":-7.832217,"marketStatus":"盤後交易","change":-2.54,"latestTime":"04-03 19:33:05 EDT","open":25,"high":26.39,"low":24,"amount":1981834.485924,"amplitude":0.088617,"askPrice":28.6,"askSize":100,"bidPrice":22,"bidSize":975,"shortable":0,"etf":0,"ttmEps":-7.832217,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1743724800000},"marketStatusCode":4,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":26.97,"preHourTrading":{"tag":"盘前","latestPrice":25.59,"preClose":26.97,"latestTime":"09:27 EDT","volume":806,"amount":20702.959523999998,"timestamp":1743686828388},"postHourTrading":{"tag":"盘后","latestPrice":24.9,"preClose":24.43,"latestTime":"17:06 EDT","volume":3,"amount":73.759998,"timestamp":1743714382387},"volumeRatio":1.043206,"impliedVol":0.4687,"impliedVolPercentile":0.5217},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","floatShares":6497315,"roa":"-18.39%","roe":"-59.37%","lyrEps":-7.832217,"volumeRatio":1.043206,"shares":11221307,"dividePrice":0,"high":26.39,"amplitude":0.088617,"preClose":26.97,"low":24,"week52Low":6.2,"pbRate":"4.38","week52High":29.27,"institutionHeld":0,"latestPrice":24.43,"committee":0.813953,"eps":-7.832217,"divideRate":0,"volume":79818,"delay":0,"ttmEps":-7.832217,"open":25,"prevYearClose":12,"prevWeekClose":28.1,"prevMonthClose":27.99,"prevQuarterClose":27.99,"fiveDayClose":27.76,"twentyDayClose":23.94,"sixtyDayClose":14.755},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":534271315,"address":"125 Strafford Avenue,Suite 360,Wayne,Pennsylvania,United States","zipCode":"19087","officePhone":"484 253 1461"},"stockCompanyDetail":{"websiteUrl":"http://www.pieris.com","stockEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.3795},{"period":"3month","weight":1.2475},{"period":"6month","weight":0.6587},{"period":"1year","weight":0.894},{"period":"ytd","weight":1.2475}],"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.033},{"period":"3month","weight":-0.0344},{"period":"6month","weight":-0.0148},{"period":"1year","weight":0.088},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Palvella Therapeutics, Inc.在內華達的法律下成立於2013年5月24日。該公司是一家生物技術公司，歷史上發現並開發了基於Anticalin蛋白的藥物，以獨特和變革性的方式靶向已驗證的疾病途徑。2024年3月27日，公司實施了措施，以最大限度地提高其從其合作候選藥物臨床管道收集潛在里程碑的能力，並保持其考慮其他戰略選擇的能力。該公司的臨床管線包括與合作者合作的免疫腫瘤學或IO雙特異性藥物，包括靶向PD-L1和4-1BB的S095012（也稱PRS-344）、靶向CD228和4-1BB的SGN-BB228（也稱PRS-346）以及靶向GPC3和4-1BB的BOS-342（也稱PRS-342）。Anticalin蛋白是公司專有的，是一類新型療法，已在臨床上通過與領先製藥公司的合作關係得到驗證。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.102904},{"month":2,"riseRate":0.5,"avgChangeRate":0.02179},{"month":3,"riseRate":0.5,"avgChangeRate":0.012293},{"month":4,"riseRate":0.2,"avgChangeRate":-0.072506},{"month":5,"riseRate":0.555556,"avgChangeRate":0.187589},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.091514},{"month":7,"riseRate":0.7,"avgChangeRate":0.124373},{"month":8,"riseRate":0.6,"avgChangeRate":0.081761},{"month":9,"riseRate":0.3,"avgChangeRate":-0.115283},{"month":10,"riseRate":0.2,"avgChangeRate":-0.082714},{"month":11,"riseRate":0.5,"avgChangeRate":0.04477},{"month":12,"riseRate":0.3,"avgChangeRate":-0.058257}],"exchange":"NASDAQ","name":"Palvella Therapeutics","nameEN":"Palvella Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":{"directors":[{"name":"James Geraghty","position":"Director and Chairman"},{"name":"Stephen S. Yoder","position":"Director,Chief Executive Officer and President"},{"name":"Ann Barbier","position":"Director"},{"name":"Christopher Kiritsy","position":"Director"},{"name":"Jean Pierre Bizzari","position":"Director"},{"name":"Michael Richman","position":"Director"},{"name":"Steven Prelack","position":"Director"}],"executives":[{"name":"Stephen S. Yoder","position":"Director,Chief Executive Officer and President"},{"name":"Allan Reine","position":"Senior Vice President, Chief Financial Officer and Treasurer"},{"name":"Louis A. Matis","position":"Senior Vice President and Chief Development Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"PVLA","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":4},{"market":"US","date":"2024-11-13","symbol":"PVLA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-2.19},{"market":"US","date":"2024-08-14","symbol":"PVLA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-2.76},{"market":"US","date":"2024-05-15","symbol":"PVLA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-3.95},{"market":"US","date":"2024-04-23","symbol":"PVLA","defaultRemindTime":1713879000000,"type":"split","dateTimestamp":1713844800000,"forFactor":80,"toFactor":1,"ratio":80}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PVLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PVLA","date":"2025-04-02","current":-15.183586,"percent":0,"low":-15.183586,"twenty":20.817306,"median":28.371332,"eighty":43.469842,"high":46.119317,"avg":29.385721,"sd":10.926182,"marketCap":264710632},"quantilePoints":[{"date":"2025-01-03","current":19.083855,"twenty":19.083855,"median":19.083855,"eighty":19.083855,"marketCap":134655684},{"date":"2025-01-10","current":22.662078,"twenty":19.083855,"median":20.077806,"eighty":23.120091,"marketCap":159903624},{"date":"2025-01-17","current":21.024047,"twenty":19.083855,"median":21.024047,"eighty":22.483962,"marketCap":148345678},{"date":"2025-01-24","current":20.658273,"twenty":19.395558,"median":20.960435,"eighty":22.003685,"marketCap":145764777},{"date":"2025-01-31","current":21.469337,"twenty":19.914003,"median":20.93658,"eighty":21.408905,"marketCap":151487644},{"date":"2025-02-07","current":23.854819,"twenty":20.19708,"median":20.960435,"eighty":22.191343,"marketCap":168319605},{"date":"2025-02-14","current":31.806426,"twenty":20.537409,"median":21.047902,"eighty":23.471552,"marketCap":224426140},{"date":"2025-02-21","current":30.216104,"twenty":20.626467,"median":21.159225,"eighty":24.999851,"marketCap":213204833},{"date":"2025-02-28","current":29.977556,"twenty":20.64237,"median":22.089563,"eighty":29.977556,"marketCap":211521636},{"date":"2025-03-07","current":38.072292,"twenty":20.658273,"median":23.043756,"eighty":30.804523,"marketCap":268638089},{"date":"2025-03-14","current":43.224933,"twenty":20.674177,"median":23.473142,"eighty":31.806426,"marketCap":304995124},{"date":"2025-03-21","current":43.622513,"twenty":20.674177,"median":24.864674,"eighty":35.527777,"marketCap":307800451},{"date":"2025-03-28","current":44.147319,"twenty":20.912725,"median":26.844623,"eighty":43.224933,"marketCap":311503482},{"date":"2025-04-02","current":-15.183586,"twenty":20.817306,"median":28.371332,"eighty":43.469842,"marketCap":264710632}],"updateTime":1743722807556}}}